Karen Hahn
Insight
Karen Hahn
Director of Global Program Management at ICON
ICON
The high investment needed to develop new medicines is leading pharmaceuticals into emerging economies like Mexico.
chapter11
Analysis
Mexico’s health industry has enjoyed substantial growth in many areas, including medical devices and generic medicines
karen hahn
View from the Top
Karen Hahn
Program Director
ICON
ICON aims to accelerate the development of medicines and medical devices. ICON employs over 13,250 people in 38 countries
MHS 2017
News Article
Mexico Health Summit 2017: Taking Mexico to the Top 10 in Clinical Research panel highlights
Ciro García
Roundtable
Ciro García
Ciro García
Director General
Accelerium Clinical Research

Mexico has strong potential to become a clinical research leader worldwide. We have all the elements, such as population, disease profile, ensemble of trained investigators and the local representation of the international bio-pharmaceutical and CRO industries, as well as the support of COFEPRIS and the most recognized agencies worldwide. However, we need to assimilate all the elements together in the most synergistic manner to significantly elevate the total number of the active trials in the coming years. Research sites should orient their activities to quality and performance to attract more research projects. Mexico accounts for less than 1 percent of all clinical research worldwide, a very low rate compared to other countries.

Mexico Health Review spoke with three CROs about the best strategies that can help Mexico become an international hub for clinical research.
Karen Hahn
View from the Top
Karen Hahn
Director of Clinical Trial Management
ICON
ICON is an international clinical research company founded in Ireland in 1990 and present in 37 countries.
Karen Hahn
View from the Top
Karen Hahn
Director of Clinical Trial Management
ICON
ICON combines best in class processes and industry leading technology, delivering impact and performance to its clients.
MHS 2015
News Article
Mexico Health Summit 2015: Attracting Clinical Trials to Mexico panel highlights
Karen Hahn
View from the Top
Karen Hahn
Director of Clinical Trial Management
ICON
ICON is a multinational company from Ireland that opened its Mexico office in 2004 and is now the largest in the region.
Subscribe to ICON